SARIOLA HANNU has a total of 13 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Finland, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are MUELLER-ENOCH DIETER, INNOVATIVE MED CONCEPTS LLC and BIOTIE THERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Finland | 3 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Czechia | 1 | |
#5 | Estonia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Norway | 1 | |
#8 | Poland | 1 | |
#9 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sariola Hannu | 13 |
#2 | Lindahl Maria | 13 |
#3 | Saarma Mart | 12 |
#4 | Xiaojuan Meng | 10 |
#5 | Hyvoenen Mervi | 6 |
#6 | Salo Mervi | 6 |
#7 | Meng Xiaojuan | 3 |
#8 | Saarma Mert | 1 |
#9 | Hyvonen Mervi | 1 |
Publication | Filing date | Title |
---|---|---|
FI20000403A0 | Use of GDNF family-related compounds for the preparation of testicular cancer treatment products | |
PL346298A1 | The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives | |
CZ2001623A3 | Use of compounds related to family of neurotrophic factor derived from glial cell line for regulating spermatogenesis and for preparing male contraception | |
FI990415A0 | Use of Compounds Related to Glial Cell Line Neurotrophic Factor Family for the Control of Spermatogenesis and Preparation of Male Contraceptives | |
FI981793A0 | Inhibition of sperm differentiation by GDNF |